Purpose: To evaluate the survival benefit of radiation plus chemotherapy in adult females
with stage IIIC endometrial cancer and to investigate whether the benefit varies according to …

Objective To evaluate whether the addition of radiation to adjuvant chemotherapy is
associated with improved survival in women with stage IV endometrial cancer following …

Objective Adjuvant therapy for advanced endometrial cancer (AEC) is not standardized. We
investigated whether regional radiotherapy with chemotherapy (CRT) compared to …

Abstract Background Stage III or IVA endometrial cancer carries a significant risk of systemic
and locoregional recurrence. Methods In this randomized phase 3 trial, we tested whether 6 …

Results The median age at diagnosis was 65 with a range of 26 to 88. Five-year survival
was 45% for patients treated with surgery alone (n= 25, 22%), 60% for patients treated with …

Objective The optimal strategy for adjuvant therapy in stage IIIC endometrial cancer has not
been determined. Our aim was to evaluate survival benefit of different treatments and to …

Purpose Our purpose was to evaluate the effect of sequence and type of adjuvant therapy
for patients with stage IIIC endometrial carcinoma (EC) on outcomes. Methods and Materials …

Objectives To determine which patients with locoregionally advanced endometrial cancer
may benefit from pelvic external beam radiotherapy (EBRT) in addition to chemotherapy …

Objective The role of the different types of adjuvant treatments in endometrial cancer with
para-aortic node metastases is unclear. The aim of this study was to report oncologic …

Hypothesis We hypothesize that adjuvant radiation and chemotherapy improve the clinical
benefit from treatment of advanced-stage endometrial adenocarcinoma. Methods We …